Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
40,225,592
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
21,851,940
-
Shares change
-
+21,804,250
-
Total reported value, excl. options
-
$388,890,872
-
Value change
-
+$388,039,143
-
Number of buys
-
50
-
Price
-
$17.86
Institutional Holders of ArriVent BioPharma, Inc. - Common Stock, $0.0001 par value (AVBP) as of Q1 2024
53 filings reported holding AVBP - ArriVent BioPharma, Inc. - Common Stock, $0.0001 par value as of 31 Mar 2024.
ArriVent BioPharma, Inc. - Common Stock, $0.0001 par value (AVBP) had 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 21,851,940 shares of stock of the company.
Largest 10 holders included HHLR ADVISORS, LTD., ORBIMED ADVISORS LLC, FMR LLC, Octagon Capital Advisors LP, Sofinnova Investments, Inc., SUVRETTA CAPITAL MANAGEMENT, LLC, General Catalyst Group Management, LLC, Novo Holdings A/S, HSG Holding Ltd, and BlackRock Inc..
This table shows the top 53 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.